CS Medica A/S (NGM:CSMED)

CS Medica Income Statement

Financials in millions DKK. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Revenue	8.46	1.07	10.58	3.18	2.11
Revenue Growth (YoY)	692.80%	-89.92%	232.85%	50.64%	48.02%
Cost of Revenue	5.25	0.15	5.96	1.5	1.43
Gross Profit	3.21	0.91	4.62	1.68	0.68
Selling, General & Admin	13.58	16.9	16.62	2.47	0.91
Other Operating Expenses	-	-0.16	-0.74	-1.99	-0.68
Operating Expenses	15.69	18.81	17.95	1.85	0.62
Operating Income	-12.48	-17.9	-13.33	-0.18	0.07
Interest Expense	-1.53	-0.57	-0.83	-0.23	-0.14
Earnings From Equity Investments	-0.46	-	-	-	-
Other Non Operating Income (Expenses)	0	0	-0	-0	0
Pretax Income	-14.47	-18.47	-14.16	-0.41	-0.08
Income Tax Expense	-4.82	-3.95	-3.36	-1.06	-0.02
Net Income	-9.65	-14.51	-10.8	0.65	-0.05
Net Income to Common	-9.65	-14.51	-10.8	0.65	-0.05
Shares Outstanding (Basic)	17	12	12	5	-
Shares Outstanding (Diluted)	17	12	12	5	-
Shares Change (YoY)	38.98%	6.12%	113.03%	-	-
EPS (Basic)	-0.56	-1.18	-0.93	0.12	-
EPS (Diluted)	-0.56	-1.18	-0.93	0.12	-
Free Cash Flow	-4.35	-8.33	-14.04	-6.02	0.67
Free Cash Flow Per Share	-0.25	-0.68	-1.21	-1.10	-
Gross Margin	37.92%	85.60%	43.66%	52.72%	32.34%
Operating Margin	-147.55%	-1677.04%	-125.99%	-5.54%	3.12%
Profit Margin	-114.06%	-1359.80%	-102.08%	20.37%	-2.59%
Free Cash Flow Margin	-51.43%	-780.39%	-132.68%	-189.30%	31.58%
EBITDA	-10.37	-17.42	-12.86	0.18	0.45
EBITDA Margin	-122.55%	-	-121.47%	5.65%	21.34%
D&A For EBITDA	2.12	0.48	0.48	0.36	0.38
EBIT	-12.48	-17.9	-13.33	-0.18	0.07
EBIT Margin	-147.55%	-	-125.99%	-5.54%	3.12%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.